查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566909

静脉水化治疗市场：按服务、按成分、按最终用户：2024-2033 年全球机会分析和产业预测

Intravenous Hydration Therapy Market By Service, By Component By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 220 Pages | 商品交期: 2-3个工作天内

价格
简介目录

静脉（IV）水化治疗市场

2023 年，静脉 (IV) 水化疗法市场价值为 23 亿美元，预计 2024 年至 2033 年复合年增长率为 7.8%，到 2033 年将达到 49 亿美元。

静脉 (IV) 水合疗法是一种透过静脉将药物、液体、维生素和电解质直接注入血液的医疗程序。这种疗法是一种非常有效的治疗方法，因为它可以有效、快速地补充因脱水而损失的必需液体和营养素。脱水是指由于某些疾病、过量饮酒、剧烈运动等导致体内多余水分流失。这种治疗方法可应用于多种医疗环境，包括慢性病的管理、术前和术后护理以及严重感染疾病和胃肠道疾病患者的治疗。

静脉（IV）水化疗法市场的主要驱动因素之一是高压力人群生活方式的日益激烈。生活压力大是个人脱水加剧的最常见原因之一。此外，世界各地的老龄化人口正在迅速增加，老年人口更容易生病和住院。这推动了对静脉水化疗法的需求并促进了市场成长。如今，静脉补水疗法作为自我护理和恢復活力的一部分非常流行，尤其是在名人中。此外，还建立了一个名为「水合吧」的专门中心，接受治疗作为放鬆的一部分。

然而，其他水合疗法（例如口服补液溶液）的可用性正在限制市场开拓。此外，缺乏专用的医疗设施和训练有素的工作人员，特别是在农村地区，为市场扩张带来了挑战。相反，治疗期间使用的传统製剂的技术进步和改进正在为市场成长提供有利可图的机会。例如，根据每个人的愿望开发个人化解决方案，帮助他们实现健康目标。

按部门审查

静脉水化治疗市场分为服务、组件、最终用户和地区。依服务划分，市场分为免疫增强剂、能量增强剂、护肤、偏头痛等。从成分来看，分为药用和非药用。依最终用户划分，可分为医院和诊所、健康中心和水疗中心、家庭医疗保健等。从区域来看，我们对北美、欧洲、亚太地区和拉丁美洲地区进行了分析。

主要发现

从服务来看，免疫增强剂占据市场主导地位。

从成分来看，医药领域在市场上获得了巨大的需求。

从最终用户来看，医院和诊所所占份额较高。

按地区划分，北美领先市场。

该报告可以定制（需要单独的费用和时间表）。

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 公司简介的扩充列表
  • 历史市场资料
  • 赎回场景

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章静脉水化治疗市场：依服务分类

  • 市场概况
  • 免疫增强剂
  • 能量助推器
  • 护肤
  • 偏头痛
  • 其他的

第五章静脉水化治疗市场：依组成部分

  • 市场概况
  • 药用
  • 非药用的

第六章静脉水化治疗市场：依最终使用者分类

  • 市场概况
  • 医院诊所
  • 健康中心/水疗中心
  • 家庭保健
  • 其他的

第七章静脉水化治疗市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国静脉 (IV) 水化治疗市场
    • 加拿大静脉水化治疗市场
    • 墨西哥静脉水化治疗市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国静脉水化治疗市场
    • 德国静脉水化治疗市场
    • 义大利静脉水化治疗市场
    • 西班牙静脉水化治疗市场
    • 英国静脉水化治疗市场
    • 其他欧洲国家静脉水化治疗市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国静脉水化治疗市场
    • 日本静脉水化疗法市场
    • 印度静脉水化治疗市场
    • 韩国静脉水化治疗市场
    • 澳洲静脉水化治疗市场
    • 其他亚太地区静脉水化治疗市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西静脉水化治疗市场
    • 南非静脉水化治疗市场
    • 沙乌地阿拉伯静脉水化治疗市场
    • 其他拉丁美洲/中东/非洲静脉水化治疗市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Davita
  • Nikkiso Co. Ltd.
  • Core IV Therapy, LLC
  • Cryojuvenate UK Ltd.
  • B. Braun Medical Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • NexGen Health
  • JW Life Science Corporation
  • Amanta Healthcare Limited.
  • Baxter International Inc.
简介目录
Product Code: A323708

Intravenous (IV) Hydration Therapy Market

The intravenous (IV) hydration therapy market was valued at $2.3 billion in 2023 and is projected to reach $4.9 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

Intravenous (IV) hydration therapy is the medical procedure in which medications, fluids, vitamins, and electrolytes are infused directly into the bloodstream through a vein. The therapy is a highly effective procedure as it ensures efficient and quick replenishment of essential fluids and nutrients lost due to dehydration. Dehydration is the excessive loss of fluids from the body caused by some illness, excessive alcohol consumption, or intense physical activity. The treatment is applicable in diverse medical settings for the management of chronic conditions, preoperative & postoperative care, and to cure patients with severe infections or gastrointestinal problems.

One of the key drivers of the intravenous (IV) hydration therapy market is increase in uptight lifestyle among individuals with high stress levels. A stressed lifestyle is one of the most common reasons for rising dehydration among individuals. In addition, the geriatric population is growing exponentially across the globe, who are highly susceptible to ailments and hospitalization. This boosts the demand for IV hydration therapy, thus augmenting the market growth. In recent times, the administration of IV therapy as a part of self-care routine or rejuvenation is trending, particularly among celebrities. Moreover, specialized centers called "hydration bars" are being established for people to receive therapy as a form of relaxation.

However, the availability of other alternatives for hydration therapy, such as the oral rehydration solutions restrain the development of the market. Furthermore, the shortage of dedicated medical facilities and well-trained staff, particularly in rural areas, presents challenges for the expansion of the market. On the contrary, advancements in technology and modifications in the conventional formulations administered during treatment are presenting lucrative opportunities for market growth. For instance, personalized solutions are being developed according to the requirements of every individual, hence aiding them to achieve their health goal.

Segment Review

The intravenous (IV) hydration therapy market is segmented into service, component, end user, and region. On the basis of service, the market is divided into immune boosters, energy boosters, skin care, migraine, and others. By component, it is bifurcated into medicated and non-medicated. As per end user, it is categorized into hospital & clinics, wellness centers & spas, home healthcare, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of service, the immune boosters segment dominates the market.

By component, the medicated segmented experiences significant demand in the market.

As per end user, the hospital & clinics segment acquires a high share of the market.

Region wise, North America leads the market.

Competition Analysis

The major players operating in the global intravenous (IV) hydration therapy market include Davita, Nikkiso Co. Ltd., Core IV Therapy, LLC, Cryojuvenate UK Ltd., B. Braun Medical Inc., Otsuka Pharmaceutical Co., Ltd., NexGen Health, JW Life Science Corporation, Amanta Healthcare Limited., and Baxter International Inc. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • Reimbursement Scenario

Key Market Segments

By Service

  • Immune boosters
  • Energy boosters
  • Skin care
  • Migraine
  • Others

By Component

  • Medicated
  • Non-medicated

By End User

  • Hospital clinics
  • Wellness centers spas
  • Home healthcare
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Davita
    • Nikkiso Co. Ltd.
    • Core IV Therapy, LLC
    • Cryojuvenate UK Ltd.
    • B. Braun Medical Inc.
    • Otsuka Pharmaceutical Co., Ltd.
    • NexGen Health
    • JW Life Science Corporation
    • Amanta Healthcare Limited.
    • Baxter International Inc.?

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY SERVICE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Service
  • 4.2. Immune Boosters
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Energy Boosters
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Skin Care
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Migraine
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Others
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY COMPONENT

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Component
  • 5.2. Medicated
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Non-medicated
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospital Clinics
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Wellness Centers Spas
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Home Healthcare
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Others
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Service
    • 7.2.3. Market Size and Forecast, By Component
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Intravenous (IV) Hydration Therapy Market
      • 7.2.6.1. Market Size and Forecast, By Service
      • 7.2.6.2. Market Size and Forecast, By Component
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Intravenous (IV) Hydration Therapy Market
      • 7.2.7.1. Market Size and Forecast, By Service
      • 7.2.7.2. Market Size and Forecast, By Component
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Intravenous (IV) Hydration Therapy Market
      • 7.2.8.1. Market Size and Forecast, By Service
      • 7.2.8.2. Market Size and Forecast, By Component
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Service
    • 7.3.3. Market Size and Forecast, By Component
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Intravenous (IV) Hydration Therapy Market
      • 7.3.6.1. Market Size and Forecast, By Service
      • 7.3.6.2. Market Size and Forecast, By Component
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Intravenous (IV) Hydration Therapy Market
      • 7.3.7.1. Market Size and Forecast, By Service
      • 7.3.7.2. Market Size and Forecast, By Component
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Intravenous (IV) Hydration Therapy Market
      • 7.3.8.1. Market Size and Forecast, By Service
      • 7.3.8.2. Market Size and Forecast, By Component
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Intravenous (IV) Hydration Therapy Market
      • 7.3.9.1. Market Size and Forecast, By Service
      • 7.3.9.2. Market Size and Forecast, By Component
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Intravenous (IV) Hydration Therapy Market
      • 7.3.10.1. Market Size and Forecast, By Service
      • 7.3.10.2. Market Size and Forecast, By Component
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Intravenous (IV) Hydration Therapy Market
      • 7.3.11.1. Market Size and Forecast, By Service
      • 7.3.11.2. Market Size and Forecast, By Component
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Service
    • 7.4.3. Market Size and Forecast, By Component
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Intravenous (IV) Hydration Therapy Market
      • 7.4.6.1. Market Size and Forecast, By Service
      • 7.4.6.2. Market Size and Forecast, By Component
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Intravenous (IV) Hydration Therapy Market
      • 7.4.7.1. Market Size and Forecast, By Service
      • 7.4.7.2. Market Size and Forecast, By Component
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Intravenous (IV) Hydration Therapy Market
      • 7.4.8.1. Market Size and Forecast, By Service
      • 7.4.8.2. Market Size and Forecast, By Component
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Intravenous (IV) Hydration Therapy Market
      • 7.4.9.1. Market Size and Forecast, By Service
      • 7.4.9.2. Market Size and Forecast, By Component
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Intravenous (IV) Hydration Therapy Market
      • 7.4.10.1. Market Size and Forecast, By Service
      • 7.4.10.2. Market Size and Forecast, By Component
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Intravenous (IV) Hydration Therapy Market
      • 7.4.11.1. Market Size and Forecast, By Service
      • 7.4.11.2. Market Size and Forecast, By Component
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Service
    • 7.5.3. Market Size and Forecast, By Component
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Intravenous (IV) Hydration Therapy Market
      • 7.5.6.1. Market Size and Forecast, By Service
      • 7.5.6.2. Market Size and Forecast, By Component
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Intravenous (IV) Hydration Therapy Market
      • 7.5.7.1. Market Size and Forecast, By Service
      • 7.5.7.2. Market Size and Forecast, By Component
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Intravenous (IV) Hydration Therapy Market
      • 7.5.8.1. Market Size and Forecast, By Service
      • 7.5.8.2. Market Size and Forecast, By Component
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Intravenous (IV) Hydration Therapy Market
      • 7.5.9.1. Market Size and Forecast, By Service
      • 7.5.9.2. Market Size and Forecast, By Component
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Davita
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Nikkiso Co. Ltd.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Core IV Therapy, LLC
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Cryojuvenate UK Ltd.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. B. Braun Medical Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Otsuka Pharmaceutical Co., Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. NexGen Health
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. JW Life Science Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Amanta Healthcare Limited.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Baxter International Inc.?
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments